独家专报！三星Galaxy Buds 3/Pro耳机参数曝光：ANC、30小时续航强势来袭

三星Galaxy Buds 3/Pro耳机参数曝光：ANC、30小时续航强势来袭

北京，2024年6月17日 - 备受期待的三星Galaxy Buds 3和Buds 3 Pro无线耳机今日参数曝光，两款耳机均支持主动降噪功能（ANC），续航时间最高可达30小时。

据悉，三星Galaxy Buds 3和Buds 3 Pro的外观设计与前代产品基本一致，采用入耳式设计，并提供多种颜色选择。两款耳机均支持IPX7防水防尘，可在户外运动等场景中使用。

在功能方面，三星Galaxy Buds 3和Buds 3 Pro均支持主动降噪功能（ANC），可有效降低周围环境噪音，为用户提供更沉浸式的聆听体验。Buds 3 Pro还支持360度音频功能，可营造更加身临其境的立体声效果。

续航方面，三星Galaxy Buds 3在开启ANC的情况下续航时间为5小时，充电盒可提供额外25小时续航，总续航时间可达30小时。Buds 3 Pro的续航时间略短，在开启ANC的情况下续航时间为6小时，充电盒可提供额外21小时续航，总续航时间为27小时。

其他方面，三星Galaxy Buds 3和Buds 3 Pro还支持快速充电功能，充电10分钟即可使用约2小时。两款耳机还支持无线充电。

据悉，三星Galaxy Buds 3和Buds 3 Pro将于下月在法国巴黎举行的Galaxy Unpacked发布会上发布，售价暂未公布。

以下是本次新闻稿的亮点：

• 三星Galaxy Buds 3和Buds 3 Pro均支持主动降噪功能（ANC）。
• Buds 3 Pro支持360度音频功能。
• 两款耳机续航时间最高可达30小时。
• 支持快速充电和无线充电。

以下是本次新闻稿的补充内容：

• 三星Galaxy Buds 3和Buds 3 Pro预计将于下月发布，售价暂未公布。
• 两款耳机将提供多种颜色选择。
• Buds 3 Pro还支持佩戴检测功能，可自动暂停音乐或播放列表，当耳机取下时恢复播放。

以下是本次新闻稿的修改建议：

• 标题可以改为“三星Galaxy Buds 3/Pro耳机强势来袭：ANC、30小时续航，应有尽有”。
• 文中可以增加一些三星Galaxy Buds 3和Buds 3 Pro的实际体验感受。
• 文末可以加入一些对未来无线耳机市场发展的展望。

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.